Zobrazeno 1 - 10
of 16
pro vyhledávání: '"L V Plastinina"'
Autor:
E S Nesterova, S K Kravchenko, A M Kovrigina, E G Gemdzhian, L V Plastinina, F E Babaeva, T N Obukhova, A U Magomedova, T V Gaponova, A M Kremenetskaya, A I Vorobyev
Publikováno v:
Терапевтический архив, Vol 91, Iss 8, Pp 75-83 (2019)
Follicular lymphoma (FL) is a tumor that develops from the B cells of the germinal center; characterized by recurrent and remitting course of the disease, the transformation of a tumor into diffuse large B-cell lymphoma (DLBCL) is possible. In genera
Externí odkaz:
https://doaj.org/article/3da6121a47664f0d8efeea23446a0aa2
Autor:
A E Misyurina, S K Kravchenko, A M Kovrigina, A U Magomedova, L V Plastinina, T N Obukhova, A V Misyurin, V A Misyurin, L A Grebenuk, F E Babaeva, E A Baryakh, A I Vorobiev
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 52-62 (2019)
Aim of the issue was to compare clinical characteristics and treatment results of patients with follicular lymphoma (FL) with translocations involving loci of c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes and patients with high - grade B-cell lymphom
Externí odkaz:
https://doaj.org/article/57c54f39fbf94c129a713cef4676acaa
Autor:
E S Nesterova, S K Kravchenko, Ya K Mangasarova, L V Plastinina, V N Dvirnyk, A M Kovrigina, I A Shchupletsova, T N Obukhova, E G Gemdzhian, I A Vorobyev, A I Vorobyev
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 45-50 (2017)
Aim. To characterize a group of patients with follicular lymphoma (FL) with leukemization and to evaluate the efficiency of different therapy options (R-CHOP/R-FMC/high-dose chemotherapy (HDCT)). Subjects and methods. 18 (7.2%) out of 250 patients di
Externí odkaz:
https://doaj.org/article/6d99647630134f33a4b2b53f2ccf3e94
Autor:
E S Nesterova, S K Kravchenko, Ya K Mangasarova, E A Baryakh, A E Misyurina, V I Vorobyev, L V Plastinina, N G Chernova, A M Kovrigina, T N Obukhova, G A Klyasova, A A Shevelev, I E Kostina, E G Gemdzhian, T V Gaponova, A I Vorobyev
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 62-71 (2016)
Aim: To evaluate the efficiency of high-dose chemotherapy (HDCT) with further autologous blood stem cell transplantation (auto-BSCT) in the first-line therapy of patients with follicular lymphoma (FL) and poor prognostic factors. Subjects and methods
Externí odkaz:
https://doaj.org/article/8a0d44c2097f492685b978067c7c045b
Publikováno v:
Онкогематология, Vol 16, Iss 2, Pp 40-47 (2021)
Cytopenia commonly occurs in case of chronic lymphocytic leukemia. It can either precede the diagnosis of chronic lymphocytic leukemia or appear at any time during the disease. Autoimmune hemolytic anemia, immune thrombocytopenia, and partial red cel
Externí odkaz:
https://doaj.org/article/c88e409eec3f41dba15511e2019d5e0a
Publikováno v:
Meditsinskiy sovet = Medical Council. :86-90
Introduction. Thanks to scientific advances and discoveries in the study of tumor cell biology, new effective drugs for the treatment of chronic lymphocytic leukemia/ small lymphocytic lymphoma have emerged. Currently, there are drugs with different
Autor:
E. S. Nesterova, S. K. Kravchenko, A. M. Kovrigina, E. G. Gemdzhian, L. V. Plastinina, Ya. K. Mangasarova, F. E. Babaeva, A. E. Misyurina, O. V. Margolin, A. U. Magomedova, V. I. Vorobiev, D. S. Maryin, E. A. Baryakh, Yu. Yu. Polyakov, P. A. Zeynalova, E. M. Volodicheva, N. N. Glonina, N. V. Minaeva, G. A. Davydova, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 13, Iss 3, Pp 10-24 (2018)
Background. Follicular lymphoma (FL) is the most common type of indolent lymphomas and accounts for 20–30 % of all non-Hodgkin’s lymphomas detected. High risk of recurrence and elderly patients make it difficult to choose induction therapy for FL
Externí odkaz:
https://doaj.org/article/cf0dfc1037f240a49382053175c77ec2
Autor:
EA Penskaya, A E Misyurina, V. V. Tikhonova, LG Gorenkova, NN Kasatkina, L. A. Kesaeva, V. A. Misyurin, N. A. Lyzhko, YuP Finashutina, A. V. Misyurin, L V Plastinina, O. N. Solopova, S K Kravchenko
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 1, Pp 73-78 (2018)
Background. T-cell lymphomas (T-CL) represent a heterogeneous group of malignant lymphoproliferative disorders characterized by unfavorable prognosis. The cancer-testis PRAME gene is notable for its spontaneous expression in transformed cells as obse
Autor:
Kravchenko Sk, Alla M. Kovrigina, Eduard G. Gemdzhian, Aminat U. Magomedova, F.E. Babaeva, A M Kremenetskaya, T N Obukhova, A I Vorobyev, T V Gaponova, E S Nesterova, L V Plastinina
Publikováno v:
Терапевтический архив, Vol 91, Iss 8, Pp 75-83 (2019)
Follicular lymphoma (FL) is a tumor that develops from the B cells of the germinal center; characterized by recurrent and remitting course of the disease, the transformation of a tumor into diffuse large B-cell lymphoma (DLBCL) is possible. In genera
Autor:
F.E. Babaeva, A E Misyurina, Aminat U. Magomedova, E S Nesterova, YaK Mangasarova, L V Plastinina, T N Obukhova, Sergei M. Kulikov, AI Vorob’ev, Alla M. Kovrigina, S K Kravchenko
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 453-463 (2017)
Background. Grade 3 follicular lymphoma (FL) is a heterogenetic group of tumors. The selections of patients with similar characteristics of the tumor process is important for classification 3 grade forms of FL and risk stratification, as well as for